http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 16 Jul 2026 12:57:33 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/Investing/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html <p data-pm-slice="1 1 []">Investing.com -- Spot silver tumbled 1.7% to $56.82 per ounce on Thursday as escalating U.S.-Iran hostilities stoked inflation fears and lifted rate-hike expectations, dragging silver mining equities sharply lower alongside the metal.</p> <p><span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Hecla Mining</span></span> (NYSE: HL), <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Coeur Mining</span></span> (NYSE: CDE), Endeavour Silver (NYSE: EXK), and <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Silvercorp Metals</span></span> (NYSE: SVM) all declined in Thursday&amp;#39;s session, amplifying the metal&amp;#39;s losses through their operating leverage to silver prices.</p> <p>Scotiabank cut its price target on Hecla to $21 from $25, citing sustained pressure on silver, a notable downgrade given that Hecla derives roughly 73% http://www.streetinsider.com/General+News/Silver+miners+slide+as+spot+price+drops+on+Iran+tensions/26778739.html Thu, 16 Jul 2026 12:57:33 -0400 CDE EKX EXK HL SLV SVM http://www.streetinsider.com/Options/iShares+Silver+Trust+%28SLV%29+spreader+of+5K+contracts+of+July+90+and+100+puts/26723248.html <p>iShares Silver Trust (NYSE: SLV) 30-day option implied volatility is at 46; compared to its 52-week range of 22 to 111. Call put ratio 1.4 calls to 1 put with a focus on a spreader of 5K contracts of July 90 and 100 puts.</p> http://www.streetinsider.com/Options/iShares+Silver+Trust+%28SLV%29+spreader+of+5K+contracts+of+July+90+and+100+puts/26723248.html Thu, 02 Jul 2026 05:50:19 -0400 SLV http://www.streetinsider.com/Options/iShares+Silver+Trust+%28SLV%29+call+put+ratio+1.3+calls+to+1+put+as+silver+pulls+back/26687912.html <p>iShares Silver Trust (NYSE: SLV) 30-day option implied volatility is at 50; compared to its 52-week range of 22 to 111. Call put ratio 1.3 calls to 1 put as silver pulls back. </p> http://www.streetinsider.com/Options/iShares+Silver+Trust+%28SLV%29+call+put+ratio+1.3+calls+to+1+put+as+silver+pulls+back/26687912.html Thu, 25 Jun 2026 06:50:56 -0400 SLV http://www.streetinsider.com/Options/iShares+Silver+Trust+%28SLV%29+call+put+ratio+1+call+to+1+put+with+a+focus+on+June+12+weekly+options/26634084.html <p>iShares Silver Trust (NYSE: SLV) 30-day option implied volatility is at 50; compared to its 52-week range of 22 to 111. Call put ratio 1 call to 1 put with a focus on June 12 weekly options.</p> http://www.streetinsider.com/Options/iShares+Silver+Trust+%28SLV%29+call+put+ratio+1+call+to+1+put+with+a+focus+on+June+12+weekly+options/26634084.html Thu, 11 Jun 2026 10:56:09 -0400 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html <p>Actinium Pharmaceuticals Inc. (NYSE American: ATNM) appointed Steffen Heeger, MD, MSc, as chief medical officer, according to a company statement.</p> <p>Heeger previously served as chief medical officer at Full-Life Technologies, where he led global development of radiotherapy programs. He also held the CMO position at NBE-Therapeutics, which was acquired by Boehringer Ingelberg for $1.4 billion.</p> <p>Earlier in his career, Heeger worked at Merck KGaA, where he led clinical development for Erbitux (cetuximab) across multiple cancer types including colorectal, head and neck, gastric, and lung cancers in the United States, Europe, Japan, and China.</p> <p>At MorphoSys AG, he served as vice president and head http://www.streetinsider.com/Management+Changes/Actinium+Pharmaceuticals+names+Steffen+Heeger+as+chief+medical+officer/26579581.html Mon, 01 Jun 2026 08:01:20 -0400 0ACX A.31197700 A.35590763 ATNM CNTA O.00284673 O.00831659 O.06705834 O.41084947 O.49013836 SLV